These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 29108515)

  • 1. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
    Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
    Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet.
    Guerra R; Auyanet I; Fernández EJ; Pérez MÁ; Bosch E; Ramírez A; Suria S; Checa MD
    J Nephrol; 2011; 24(1):78-82. PubMed ID: 20437396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation].
    Vaquero E; Esteban de la Rosa RJ; Oliva N; Fernández Castillo R; Fernández Gallegos R; Bravo Soto J
    Med Clin (Barc); 2012 Apr; 138(8):323-6. PubMed ID: 21492884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
    JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study.
    Aalten J; Wetzels JF; Hoitsma AJ
    Clin Nephrol; 2010 Dec; 74(6):433-9. PubMed ID: 21084046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
    Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation.
    Ważna-Jabłońska E; Gałązka Z; Durlik M
    Transplant Proc; 2016 Jun; 48(5):1623-5. PubMed ID: 27496458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients.
    Sharma AK; Masterson R; Holt SG; Tan SJ; Hughes PD; Chu M; Jayadeva P; Toussaint ND
    Nephrology (Carlton); 2016 Jan; 21(1):46-54. PubMed ID: 26072678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation.
    Pinho LR; Ribeiro Santos MJ; Pestana Vasconcelos M
    Clin Nephrol; 2011 Mar; 75(3):263-8. PubMed ID: 21329638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
    Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM
    Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
    Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
    J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of calcimimetics after dialysis: same effectiveness, better gastrointestinal tolerability.
    Esteve Simo V; Moreno-Guzmán F; Martínez Calvo G; Fulquet Nicolas M; Pou Potau M; Macias-Toro J; Duarte-Gallego V; Saurina Sole A; Ramírez-de Arellano Serna M
    Nefrologia; 2015; 35(4):403-9. PubMed ID: 26306967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
    Apostolou T; Damianou L; Kotsiev V; Drakopoulos S; Hadjiconstantinou V
    Clin Nephrol; 2006 May; 65(5):374-7. PubMed ID: 16724661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
    Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G
    Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation.
    Al-Moasseb Z; Aitken E
    Transplant Proc; 2016 Dec; 48(10):3285-3291. PubMed ID: 27931570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
    López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
    Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term efficacy and safety of treatment with cinacalcet in hypercalcemic persistent secondary hyperparathyroidism in renal transplant].
    Massimetti C; Di Napoli A; Feriozzi S
    G Ital Nefrol; 2022 Jun; 39(3):. PubMed ID: 35819043
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance and efficacy of a low dose of the calcimimetic agent cinacalcet in controlling moderate to severe secondary hyperparathyroidism in hemodialysis patients.
    Bashir SO; Omer HA; Aamer MA; Somialy R; Morsy MD
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1135-41. PubMed ID: 26586050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
    Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP
    Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.